ENTPD1 and multiple sclerosis: Defective numbers of CD39+ T-reg have been reported in patients with multiple sclerosis, autoimmune hepatitis [33] and CD39 polymorphisms linked to low-level CD39 expression have also been described in Crohn’s disease [30], [32], [34].